Rezolute Reports Fourth Quarter and Full Year Fiscal 2022 Results and Highlights Company Progress
Announced a $130 million registered direct offering and concurrent private placement priced at-the-market Late-breaking oral presentation from Phase 2b RIZE study of RZ358 presented at ESPE 2022 Phase 2 proof-of-concept study of RZ402 expected to be …